James Kim, MD, PhD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    COTA Inc
    Topic: 
    Consulting for biomarkers in lung cancer
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Sanofi
    Topic: 
    Scientific Advisory Board on Lung Cancer
Return to 109 DIVISION OF HEM/ONC: ONCOLOGY BOARD REVIEW CONFERENCE "Stage IV Lung Cancer without Molecular Targets" (082522)